| Year |
Citation |
Score |
| 2024 |
Whitman MA, Mantri M, Spanos E, Estroff LA, De Vlaminck I, Fischbach C. Bone mineral density affects tumor growth by shaping microenvironmental heterogeneity. Biomaterials. 315: 122916. PMID 39490060 DOI: 10.1016/j.biomaterials.2024.122916 |
0.414 |
|
| 2024 |
Whitman MA, Mantri M, Spanos E, Estroff LA, De Vlaminck I, Fischbach C. Bone mineral density affects tumor growth by shaping microenvironmental heterogeneity. Biorxiv : the Preprint Server For Biology. PMID 39091735 DOI: 10.1101/2024.07.19.604333 |
0.43 |
|
| 2023 |
Choi S, Whitman MA, Shimpi AA, Sempertegui ND, Chiou AE, Druso JE, Verma A, Lux SC, Cheng Z, Paszek M, Elemento O, Estroff LA, Fischbach C. Bone-matrix mineralization dampens integrin-mediated mechanosignalling and metastatic progression in breast cancer. Nature Biomedical Engineering. PMID 37550422 DOI: 10.1038/s41551-023-01077-3 |
0.587 |
|
| 2020 |
Chatterjee N, Whitman MA, Harris CA, Min SM, Jonas O, Lien EC, Luengo A, Vander Heiden MG, Hong J, Zhou P, Hemann MT, Walker GC. REV1 inhibitor JH-RE-06 enhances tumor cell response to chemotherapy by triggering senescence hallmarks. Proceedings of the National Academy of Sciences of the United States of America. PMID 33168727 DOI: 10.1073/pnas.2016064117 |
0.312 |
|
| 2018 |
Watson SS, Dane M, Chin K, Tatarova Z, Liu M, Liby T, Thompson W, Smith R, Nederlof M, Bucher E, Kilburn D, Whitman M, Sudar D, Mills GB, Heiser LM, et al. Microenvironment-Mediated Mechanisms of Resistance to HER2 Inhibitors Differ between HER2+ Breast Cancer Subtypes. Cell Systems. PMID 29550255 DOI: 10.1016/j.cels.2018.02.001 |
0.353 |
|
| Show low-probability matches. |